Alana McNulty

2021

In 2021, Alana McNulty earned a total compensation of $1.7M as Chief Business Officer at eFFECTOR Therapeutics, a 198% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$128,000
Salary$383,814
Stock Awards$1,168,270
Other$30,264
Total$1,710,348

McNulty received $1.2M in stock awards, accounting for 68% of the total pay in 2021.

McNulty also received $128K in non-equity incentive plan, $383.8K in salary and $30.3K in other compensation.

Rankings

In 2021, Alana McNulty's compensation ranked 6,691st out of 12,406 executives tracked by ExecPay. In other words, McNulty earned more than 46.1% of executives.

ClassificationRankingPercentile
All
6,691
out of 12,406
46th
Division
Manufacturing
2,896
out of 5,492
47th
Major group
Chemicals And Allied Products
1,273
out of 2,368
46th
Industry group
Drugs
1,135
out of 2,089
46th
Industry
Pharmaceutical Preparations
824
out of 1,536
46th
Source: SEC filing on April 20, 2022.

McNulty's colleagues

We found three more compensation records of executives who worked with Alana McNulty at eFFECTOR Therapeutics in 2021.

2021

Stephen Worland

eFFECTOR Therapeutics

Chief Executive Officer

2021

Premal Patel

eFFECTOR Therapeutics

Chief Medical Officer

2021

Michael Byrnes

eFFECTOR Therapeutics

Chief Financial Officer

News

You may also like